☆ 4.7 Article

Postnatal corticosteroid exposure in very preterm infants: A French cohort study

FRONTIERS IN PHARMACOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Pediatrics

Postnatal corticosteroids and developmental outcomes in extremely preterm or extremely low birth weight infants: The Victorian Infant Collaborative Study 2016-17 cohort

Ellen Douglas et al.

Summary: This study aimed to assess the relationship between cumulative postnatal corticosteroid dose and neurodevelopmental outcomes. The study found that higher cumulative corticosteroid dose in extremely low birth weight infants was associated with increased odds of cerebral palsy. However, further adequately powered studies are needed to evaluate the independent effects of cumulative steroid dose on neurodevelopmental outcomes.

ACTA PAEDIATRICA (2023)

添加到收藏夹

Article Pediatrics

Risk factors and bronchopulmonary dysplasia severity: data from the Spanish Bronchopulmonary Dysplasia Research Network

Cristina Ramos-Navarro et al.

Summary: GEIDIS is a national-based research-net registry for patients with bronchopulmonary dysplasia (BPD) in Spanish hospitals, aiming to provide data on clinical characterization and follow-up. The study found that the main risk factor for BPD severity is the duration of mechanical ventilation, with male gender, oligohydramnios, and intrauterine growth restriction as independent prenatal risk factors.

EUROPEAN JOURNAL OF PEDIATRICS (2022)

添加到收藏夹

Article Medicine, General & Internal

Hydrocortisone to Improve Survival without Bronchopulmonary Dysplasia

K. L. Watterberg et al.

Summary: This trial found that hydrocortisone treatment starting on postnatal day 14 to 28 did not significantly improve the survival without moderate or severe bronchopulmonary dysplasia compared to placebo. The survival without moderate or severe neurodevelopmental impairment also did not differ significantly between the two groups.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Article Medicine, General & Internal

Dexamethasone, Prednisolone, and Methyiprednisolone Use and 2-Year Neurodevelopmental Outcomes in Extremely Preterm Infants

Mihai Puia-Dumitrescu et al.

Summary: This study aimed to describe the use of corticosteroids in extremely preterm infants and evaluate their association with neurodevelopmental outcomes. The results showed that long-duration and higher cumulative dose of dexamethasone were associated with worse neurodevelopmental scores at 2 years of age.

JAMA NETWORK OPEN (2022)

添加到收藏夹

Article Medicine, General & Internal

Postnatal corticosteroid use for prevention or treatment of bronchopulmonary dysplasia in England and Wales 2012-2019: a retrospective population cohort study

Sijia Yao et al.

Summary: This study describes the population of babies who do and do not receive postnatal corticosteroids for the prevention or treatment of bronchopulmonary dysplasia (BPD) in England and Wales. It found that approximately 1 in 12 babies born less than 32 weeks and 1 in 4 born less than 27 weeks received postnatal corticosteroids for BPD. Dexamethasone was the most commonly used corticosteroid, and its use increased over time.

BMJ OPEN (2022)

添加到收藏夹

Article Medicine, General & Internal

Hydrocortisone to Improve Survival without Bronchopulmonary Dysplasia

K. L. Watterberg et al.

Summary: In this trial involving preterm infants, hydrocortisone treatment starting on postnatal day 14 to 28 did not result in substantially higher survival without moderate or severe bronchopulmonary dysplasia than placebo. Survival without moderate or severe neurodevelopmental impairment did not differ substantially between the two groups.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Review Pediatrics

Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia

Lex W. Doyle

Summary: Bronchopulmonary dysplasia (BPD) is a major morbidity for preterm infants, and corticosteroids may have both benefits and adverse effects in preventing and treating it. Inhaled corticosteroids started early may reduce BPD but increase mortality, while systemic corticosteroids started after the first week of age may reduce both BPD and mortality, with no evidence of long-term neurological harm. However, there is a need for further research to evaluate important adverse long-term neurological effects.

NEONATOLOGY (2021)

添加到收藏夹

Article Pediatrics

Association of time of first corticosteroid treatment with bronchopulmonary dysplasia in preterm infants

Alain Cuna et al.

Summary: Among preterm infants treated with systemic corticosteroids, later initiation of treatment was associated with a higher likelihood of developing Grade 2 or 3 BPD compared to earlier treatment.

PEDIATRIC PULMONOLOGY (2021)

添加到收藏夹

Review Medicine, General & Internal

Early (< 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants

Lex W. Doyle et al.

Summary: Early systemic postnatal corticosteroid treatment can prevent bronchopulmonary dysplasia (BPD) and the combined outcome of mortality or BPD, but it may increase risks of gastrointestinal perforation, cerebral palsy, and the combined outcome of mortality or cerebral palsy. Most beneficial and harmful effects are related to early treatment with dexamethasone rather than hydrocortisone, although hydrocortisone may help prevent mortality. Long-term follow-up into late childhood is crucial for assessing the impact of early corticosteroid treatment on higher-order neurological functions. Further research on early corticosteroids, especially hydrocortisone, should prioritize longer-term survival free of neurodevelopmental disability as the primary outcome.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)

添加到收藏夹

Article Obstetrics & Gynecology

Timing of postnatal steroids for bronchopulmonary dysplasia: association with pulmonary and neurodevelopmental outcomes

Heidi M. Harmon et al.

JOURNAL OF PERINATOLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation A Randomized Clinical Trial

Wes Onland et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

添加到收藏夹

Review Obstetrics & Gynecology

Update on Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia

Marco Filippone et al.

AMERICAN JOURNAL OF PERINATOLOGY (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Characteristics of prescription in 29 Level 3 Neonatal Wards over a 2-year period (2017-2018). An inventory for future research

Beatrice Gouyon et al.

PLOS ONE (2019)

添加到收藏夹

Article Pediatrics

Effect of Prophylaxis for Early Adrenal Insufficiency Using Low-Dose Hydrocortisone in Very Preterm Infants: An Individual Patient Data Meta-Analysis

Michele L. Shaffer et al.

JOURNAL OF PEDIATRICS (2019)

添加到收藏夹

Article Pharmacology & Pharmacy

A Computer Prescribing Order Entry-Clinical Decision Support system designed for neonatal care: results of the preselected prescription' concept at the bedside

B. Gouyon et al.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2017)

添加到收藏夹

Article Medicine, General & Internal

Association Between Early Low-Dose Hydrocortisone Therapy in Extremely Preterm Neonates and Neurodevelopmental Outcomes at 2 Years of Age

Olivier Baud et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Evidence-Based Neonatal Unit Practices and Determinants of Postnatal Corticosteroid-Use in Preterm Births below 30 Weeks GA in Europe. A Population-Based Cohort Study

Alexandra Nuytten et al.

PLOS ONE (2017)

添加到收藏夹

Review Medicine, General & Internal

Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants

Wes Onland et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)

添加到收藏夹

Article Medicine, General & Internal

Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial

Olivier Baud et al.

LANCET (2016)

添加到收藏夹

Article Medicine, General & Internal

Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia

Dirk Bassler et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

添加到收藏夹

Review Medicine, General & Internal

Corticosteroids for treating hypotension in preterm infants

Hafis Ibrahim et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2011)

添加到收藏夹

Article Pediatrics

The use of postnatal corticosteroid therapy in premature infants to prevent or treat bronchopulmonary dysplasia: Current situation and recommendations

P. -H. Jarreau et al.

ARCHIVES DE PEDIATRIE (2010)

添加到收藏夹

Article Pediatrics

Trial of Early Neonatal Hydrocortisone: Two-Year Follow-Up

Outi M. Peltoniemi et al.

NEONATOLOGY (2009)

添加到收藏夹

Review Medicine, General & Internal

Corticosteroids for the prevention and treatment of post-extubation stridor in neonates, children and adults

R. G. Khemani et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2009)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.